XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.480
-0.030 (-1.20%)
At close: Dec 5, 2025, 4:00 PM EST
2.493
+0.013 (0.52%)
After-hours: Dec 5, 2025, 4:10 PM EST
XBiotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 76 | 120 | 122 | 107 | 338 | 458 | |
| Market Cap Growth | -62.81% | -1.10% | 13.95% | -68.42% | -26.11% | -40.29% | |
| Enterprise Value | -72 | -53 | -80 | -113 | 99 | 219 | |
| Last Close Price | 2.48 | 3.95 | 4.00 | 3.51 | 11.13 | 13.51 | |
| PS Ratio | - | - | - | 26.64 | 18.39 | 10.41 | |
| PB Ratio | 0.45 | 0.66 | 0.56 | 0.44 | 1.26 | 1.31 | |
| P/TBV Ratio | 0.45 | 0.66 | 0.56 | 0.44 | 1.26 | 1.31 | |
| P/FCF Ratio | - | - | - | - | 5.13 | - | |
| P/OCF Ratio | - | - | - | - | 4.87 | - | |
| EV/Sales Ratio | - | - | - | - | 5.41 | 4.99 | |
| EV/FCF Ratio | - | - | - | - | 1.51 | - | |
| Debt / Equity Ratio | - | 0.06 | - | - | - | - | |
| Asset Turnover | - | - | - | 0.02 | 0.06 | 0.08 | |
| Quick Ratio | 41.48 | 11.49 | 32.94 | 53.92 | 71.22 | 62.26 | |
| Current Ratio | 41.78 | 11.56 | 33.07 | 54.07 | 71.49 | 81.80 | |
| Return on Equity (ROE) | -16.23% | -19.21% | -10.69% | -12.91% | -5.63% | -2.03% | |
| Return on Assets (ROA) | -11.34% | -12.47% | -9.92% | -8.27% | -4.98% | -1.95% | |
| Return on Capital (ROIC) | -11.74% | -12.90% | -10.21% | -8.46% | -5.07% | -2.07% | |
| Return on Capital Employed (ROCE) | -20.50% | -23.10% | -17.00% | -14.20% | -9.20% | -5.20% | |
| Earnings Yield | -38.56% | -32.00% | -20.17% | -30.79% | -5.15% | -2.45% | |
| FCF Yield | -31.54% | -26.80% | -15.68% | -14.42% | 19.48% | -15.04% | |
| Buyback Yield / Dilution | -0.09% | -0.07% | 0.00% | -1.32% | 2.53% | 33.45% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.